News

Technology News

Exosome Diagnostics Publishes Positive Results

Monday, May 18, 2015 5:00:00 AM PDT | VentureDeal
   New Orleans, Louisiana  --  Exosome Diagnostics has announced positive results from a large clinical study of its prostate cancer liquid biopsy test.

The company said that the study met its primary endpoint, which was to demonstrate that the urine-based test improves the ability to accurately predict high grade prostate cancer in men presenting for an initial biopsy.

The study consisted of 22 clinical sites testing men 50 years or older who were scheduled for an initial biopsy.

The test was able to provide a high predictability as well as a high negative predictive value.

The value of the test is that it is non-invasive and is "being designed to enable physicians, along with PSA and other SOC factors, to more accurately predict whether a patient presenting for initial biopsy does not have high-grade prostate cancer."

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1